General Information of Drug (ID: DMQMXIO)

Drug Name
LEURUBICIN
Synonyms
Doxogenix L; CT-012002; L-ADR; LEU-DOX; RP-39937; Leurubicin; N-L-Leucyladriamycin; N-L-Leucyldoxorubicin; E-88/032 (hydrochloride); (8S,10S)-10-[[3-[(S)-2-Amino-4-methylvaleramido]-2,3,6-trideoxy-alphal-L-lyxo-hexopyranosyl]oxy]-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; (8S-cis)-6,8,11-Trihydroxy-8-(hydroxyacetyl)-10-[2,3,6-trideoxy-3-(L-leucylamino)-alpha-L-lyxohexopyranosyloxy]-1-methoxy-5,8,9,10,12-hexahydronaphthacene-5,12-dione
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C33H40N2O12
Canonical SMILES
CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NC(=O)C(CC(C)C)N)O
InChI
InChI=1S/C33H40N2O12/c1-13(2)8-17(34)32(43)35-18-9-22(46-14(3)27(18)38)47-20-11-33(44,21(37)12-36)10-16-24(20)31(42)26-25(29(16)40)28(39)15-6-5-7-19(45-4)23(15)30(26)41/h5-7,13-14,17-18,20,22,27,36,38,40,42,44H,8-12,34H2,1-4H3,(H,35,43)/t14-,17-,18-,20-,22-,27+,33-/m0/s1
InChIKey
HROXIDVVXKDCBD-ZUWKMVCBSA-N
Cross-matching ID
PubChem CID
68897
CAS Number
70774-25-3
TTD ID
D0T5XN
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001292)